
Dr Sylvain Fraineau and collaborators obtained funding for a collaborative project from ERA4Health 2025 call "Understanding the interactions between cardiovascular diseases and comorbidities and/or their therapeutic treatments (InterHeart)". The project RESIDE, "Role of Ezh2 in aortic Stenosis Initiation and DEvelopment", will assemble 5 european teams:
- Partner 1: INSERM UMR1096/ CHU of Rouen, Rouen, France (project co-ordinator, Dr Sylvain Fraineau)
- Partner 2: Genomics and Bioinformatics Lab. Department of Pharmaceutical Sciences. Faculty of Medicine and Life Sciences, University of Latvia, Riga, Latvia (Dr Trapina, Ilva)
- Partner 3: Laboratory of Hematovascular Pathophysiology. Spanish National Center for Cardiovascular Research (CNIC), Madrid, Spain (Dr Fuster Ortuño, José Javieri)
- Partner 4: August Krogh Section for Human and Molecular Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Denmark (Dr Nossent, Anne Yaël)
- Partner 5: Paris Cardiovascular Research Center (PARCC)-INSERM U970, University Paris Cité, Paris, France (Dr Cochain, Clément)
The RESIDE project, funded with €1.17 million under the European ERA4Health InterHeart 2025 call, will begin in January 2026 and run for three years. Coordinated by Dr. Sylvain Fraineau (INSERM Unit U1096 EnVI, Rouen – directed by Prof. Jérémy Bellien), the project aims to elucidate the role of the epigenetic enzyme EZH2 in the development of calcific aortic stenosis induced by myeloid cells. For more information see project website RESIDE
RESIDE is structured around three main objectives:
-
To study the role of EZH2 in the inflammatory properties of circulating monocytes in patients;
-
To assess the importance of EZH2 during the myofibroblastic and osteogenic differentiation of valvular interstitial cells induced by infiltrating myeloid cells; and
-
To evaluate EZH2 as a therapeutic target specific to circulating and infiltrated myeloid cells, in order to limit disease progression.
This project, associated with the Cribier Institute for Cardiac Valves, builds on the work carried out during the RHU STOP-AS program by the Cardiology Department of Rouen University Hospital (Profs. Hélène Eltchaninoff and Eric Durand) and the INSERM U1096 EnVI research unit.
